Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin αIIb β3 binding in human platelets.
about
Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin αIIb β3 binding in human platelets.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Norcantharidin, a clinical use ...... β3 binding in human platelets.
@en
Norcantharidin, a clinical use ...... β3 binding in human platelets.
@nl
type
label
Norcantharidin, a clinical use ...... β3 binding in human platelets.
@en
Norcantharidin, a clinical use ...... β3 binding in human platelets.
@nl
prefLabel
Norcantharidin, a clinical use ...... β3 binding in human platelets.
@en
Norcantharidin, a clinical use ...... β3 binding in human platelets.
@nl
P2093
P2860
P356
P1476
Norcantharidin, a clinical use ...... β3 binding in human platelets
@en
P2093
Duen-Suey Chou
Joen-Rong Sheu
Kuan-Hung Lin
Nen-Chung Chang
Pitchairaj Geraldine
Thanasekaran Jayakuma
Wan-Jung Lu
P2860
P304
P356
10.1111/JCMM.13488
P577
2018-01-25T00:00:00Z